Abstract
An absolute cerebral blood flow (CBF) measurement is necessary for detection of diffuse cerebral involvement and helpful for management of patients. Of the various measurement methods that have been employed in single photon emission computed tomography (SPECT), a noninvasive method using radionuclide angiography of 99mTc-labeled tracers has been widely used because of its simplicity without the need for any blood sampling. Brain perfusion index (BPI) is determined by graphical analysis of time activity curves for aortic arch and brain within 30 s immediately after bolus injection of the tracer. This BPI is converted to global CBF using a regression line equation between BPI and global CBF measured using 133Xe-SPECT. Then, regional CBF is calculated from global CBF, a linearization correction factor, and global mean SPECT counts. Obtained CBF values show good correlations with those obtained by other invasive methods with arterial blood sampling. This noninvasive technique has been applied to various neuropsychiatric diseases including cerebrovascular diseases, neurodegenerative disorders, and mood disorders for the early and differential diagnosis and objective evaluation of therapeutic effects.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Abumiya T, Katoh M, Moriwaki T et al (2014) Utility of early post-treatment single-photon emission computed tomography imaging to predict outcome in stroke patients treated with intravenous tissue plasminogen activator. J Stroke Cerebrovasc Dis 23:896–901
Andersen AR, Friberg HH, Schmidt JF et al (1988) Quantitative measurements of cerebral blood flow using SPECT and [99mTc]-d,l-HM-PAO compared to xenon-133. J Cereb Blood Flow Metab 8:S69–S81
Chang C-C, Asada H, Mimura T et al (2009) A prospective study of cerebral blood flow and cerebrovascular reactivity to acetazolamide in 162 patients with idiopathic normal-pressure hydrocephalus: clinical article. J Neurosurg 111:610–617
Choi BR, Kim JS, Yang YJ et al (2006) Factors associated with decreased cerebral blood flow in congestive heart failure secondary to idiopathic dilated cardiomyopathy. Am J Cardiol 97:1365–1369
Friberg L, Andersen AR, Lassen NA et al (1994) Retention of 99mTc-bicisate in the human brain after intracarotid injection. J Cereb Blood Flow Metab 14(Suppl 1):S19–S27
Fujimoto S, Toyoda K, Inoue T et al (2004) Diagnostic impact of transcranial color-coded real-time sonography with echo contrast agents for hyperperfusion syndrome after carotid endarterectomy. Stroke 35:1852–1856
Garai I, Varga J, Szomj E et al (2002) Quantitative assessment of blood flow reserve using 99mTc-HMPAO in carotid stenosis. Eur J Nucl Med 29:216–220
Groiselle C, Rocchisani J-M, Moretti J-L (2000) Improving the measurement of the 99Tcm-ECD brain perfusion index by temporal analysis. Nucl Med Commun 21:811–816
Hofman PAM, Stapert SZ, Van Kroonenburgh MJ et al (2001) MR imaging, single-photon emission CT, and neurocognitive performance after mild traumatic brain injury. AJNR Am J Neuroradiol 22:441–449
Honjo K, Ohshita T, Kawakami H et al (2004) Quantitative assessment of cerebral blood flow in genetically confirmed spinocerebellar ataxia type 6. Arch Neurol 61:933–937
Hossain AKMM, Murata Y, Zhang L et al (2003) Brain perfusion SPECT in patients with corticobasal degeneration: analysis using statistical parametric mapping. Mov Disord 18:697–703
Iida H, Itoh H, Nakazawa M et al (1994) Quantitative mapping of regional cerebral blood flow using iodine-123-IMP and SPECT. J Nucl Med 35:2019–2030
Iidaka T, Nakajima T, Suzuki Y et al (1997) Quantitative regional cerebral blood flow measured by Tc-99m HMPAO SPECT in mood disorder. Psychiatry Res 68:143–154
Ikeda K, Aoyagi J, Hanashiro S et al (2018) Preventive treatment with lomerizine increases cerebral blood flows during the interictal phase of migraine. J Stroke Cerebrovasc Dis 27:998–1002
Imabayashi E, Yokoyama K, Tsukamoto T et al (2016) The cingulate island sign within early Alzheimer's disease-specific hypoperfusion volumes of interest is useful for differentiating Alzheimer's disease from dementia with Lewy bodies. EJNMMI Res 6:67
Imasaka K, Yasaka M, Tayama E et al (2015) Obstructive carotid and/or intracranial artery disease rarely affects the incidence of haemodynamic ischaemic stroke during cardiac surgery: a study on brain perfusion single-photon emission computed tomography with acetazolamide. Eur J Cardiothorac Surg 48:739–746
Imon Y, Matsuda H, Ogawa M et al (1999) SPECT image analysis using statistical parametric mapping in patients with Parkinson's disease. J Nucl Med 40:1583–1589
Inoue Y, Momose T, Ohtake T et al (1997) Effect of deadtime loss on quantitative measurement of cerebral blood flow with technetium-99m hexamethylpropylene amine oxime. Eur J Nucl Med 24:1418–1421
Ishibashi M, Kimura N, Aso Y et al (2018) Effects of white matter lesions on brain perfusion in patients with mild cognitive impairment. Clin Neurol Neurosurg 168:7–11
Iwata T, Mori T, Tajiri H et al (2011) Predictors of hyperperfusion syndrome before and immediately after carotid artery stenting in single-photon emission computed tomography and transcranial color-coded real-time sonography studies. Neurosurgery 68:649–655
Johnson B, Barron B, Fang B et al (1998a) Isradipine prevents global and regional cocaine-induced changes in brain blood flow: a preliminary study. Psychopharmacology 136:335–341
Johnson B, Lamki L, Fang B et al (1998b) Demonstration of dose-dependent global and regional cocaine-induced reductions in brain blood flow using a novel approach to quantitative single photon emission computerized tomography. Neuropsychopharmacology 18:377–384
Kamishirado H, Inoue T, Fujito T et al (1997) Effect of enalapril maleate on cerebral blood flow in patients with chronic heart failure. Angiology 48:707–713
Káplár M, Paragh G, Erdei A et al (2009) Changes in cerebral blood flow detected by SPECT in type 1 and type 2 diabetic patients. J Nucl Med 50:1993–1998
Kim M-S, Kim J-S, Yun S-C et al (2012) Association of cerebral blood flow with the development of cardiac death or urgent heart transplantation in patients with systolic heart failure. Eur Heart J 33:354–362
Kimura N, Hanaki S, Masuda T et al (2011) Brain perfusion differences in parkinsonian disorders. Mov Disord 26:2530–2537
Kimura N, Kumamoto T, Masuda T et al (2012) Evaluation of the regional cerebral blood flow changes during long-term donepezil therapy in patients with Alzheimer's disease using 3DSRT. J Neuroimaging 22:299–304
Kinuya K, Kakuda K, Nobata K et al (2004) Role of brain perfusion single-photon emission tomography in traumatic head injury. Nucl Med Commun 25:333–337
Kogure D, Matsuda H, Ohnishi T et al (2000) Longitudinal evaluation of early Alzheimer's disease using brain perfusion SPECT. J Nucl Med 41:1155–1162
Lassen NA, Andersen AR, Friberg L et al (1988) The retention of [99mTc]-d,l-HM-PAO in the human brain after intracarotid bolus injection: a kinetic analysis. J Cereb Blood Flow Metab 8:S13–S22
Latchaw RE, Yonas H, Hunter GJ et al (2003) Guidelines and recommendations for perfusion imaging in cerebral ischemia: a scientific statement for healthcare professionals by the Writing Group on Perfusion Imaging, from the Council on Cardiovascular Radiology of the American Heart Association. Stroke 34:1084–1104
Masunaga Y, Uchiyama Y, Ofuji A et al (2014) Development of an automatic ROI setting program for input function determination in 99mTc-ECD non-invasive cerebral blood flow quantification. Phys Med 30:513–520
Matsuda H, Tsuji S, Shuke N et al (1992) A quantitative approach to technetium-99m hexamethylpropylene amine oxime. Eur J Nucl Med 19:195–200
Matsuda H, Tsuji S, Shuke N et al (1993) Noninvasive measurements of regional cerebral blood flow using technetium-99m hexamethylpropylene amine oxime. Eur J Nucl Med 20:391–401
Matsuda H, Yagishita A, Tsuji S et al (1995) A quantitative approach to technetium-99m ethyl cysteinate dimer: a comparison with technetium-99m hexamethylpropylene amine oxime. Eur J Nucl Med 22:633–637
McKeith IG, Boeve BF, Dickson DW et al (2017) Diagnosis and management of dementia with Lewy bodies: fourth consensus report of the DLBConsortium. Neurology 89:88–100
Murase K, Inoue T, Fujioka H et al (1999) An alternative approach to estimation of the brain perfusion index for measurement of cerebral blood flow using technetium-99m compounds. Eur J Nucl Med 26:1333–1339
Murase K, Fujioka H, Inoue T et al (2001) Reproducibility of the brain perfusion index for measuring cerebral blood flow using technetium-99m compounds. Eur J Nucl Med 28:1640–1646
Nakabeppu Y, Nakajo M, Gushiken T et al (2001) Decreased perfusion of the bilateral thalami in patients with chronic pain detected by Tc-99m-ECD SPECT with statistical parametric mapping. Ann Nucl Med 15:459–463
Nanri K, Okita M, Takeguchi M et al (2009) Intravenous immunoglobulin therapy for autoantibody-positive cerebellar ataxia. Intern Med 48:783–790
Narita H, Odawara T, Iseki E et al (2004) Psychomotor retardation correlates with frontal hypoperfusion and the modified Stroop test in patients with major depression under 60-years-old. Psychiatry Clin Neurosci 58:389–395
Nazir FS, Overell JR, Bolster A et al (2004) The effect of losartan on global and focal cerebral perfusion and on renal function in hypertensives in mild early ischaemic stroke. J Hypertens 22:989–995
Nazir FS, Overell JR, Bolster A et al (2005) Effect of perindopril on cerebral and renal perfusion on normotensives in mild early ischaemic stroke: a randomized controlled trial. Cerebrovasc Dis 19:77–83
Ohgami H, Nagayama H, Akiyoshi J et al (2005) Contributing factors to changes of cerebral blood flow in major depressive disorder. J Affect Disord 87:57–63
Okada K, Suyama N, Oguro H et al (1999) Medication-induced hallucination and cerebral blood flow in Pfarkinson's disease. J Neurol 246:365–368
Patlak CS, Blasberg RG, Fenstermacher JD (1983) Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data. J Cereb Blood Flow Metab 3:1–7
Patlak CS, Blasberg RG (1985) Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data. Generalizations. J Cereb Blood Flow Metab 5:584–590
Shiga Y, Tsuda T, Itoyama Y et al (2002) Transcranial magnetic stimulation alleviates truncal ataxia in spinocerebellar degeneration. J Neurol Neurosurg Psychiatry 72:124–126
Shimosegawa E, Hatazawa J, Inugami A et al (1994) Cerebral infarction within six hours of onset: prediction of completed infarction with technetium-99m-HMPAO SPECT. J Nucl Med 35:1097–1103
Suzuki Y, Oishi M, Ogawa K et al (2010) Atrophy of the parahippocampal gyrus and regional cerebral blood flow in the limbic system in chronic alcoholic patients. Alcohol 44:439–445
Tabei KI, Kida H, Hosoya T et al (2017) Prediction of cognitive decline from white matter hyperintensity and single-photon emission computed tomography in Alzheimer's disease. Front Neurol 8:408
Takasawa M, Murase K, Oku N et al (2002) Assessment of acetazolamide reactivity in cerebral blood flow using spectral analysis and technetium-99m hexamethylpropylene amine oxime. J Cereb Blood Flow Metab 22:1004–1009
Takasawa M, Murase K, Oku N et al (2003) Interobserver variability of cerebral blood flow measurements obtained using spectral analysis and technetium-99m labeled compounds. Ann Nucl Med 17:255–259
Takasawa M, Murase K, Oku N et al (2004) Spectral analysis of 99mTc-HMPAO, for estimating cerebral blood flow: a comparison with H2 15O PET. Ann Nucl Med 18:243–249
Takeuchi R, Matsuda H, Yonekura Y et al (1997) Noninvasive quantitative measurements of regional cerebral blood flow using technetium-99m-L,L-ECD SPECT activated with acetazolamide: quantification analysis by equal-volume-split 99mTc-ECD consecutive SPECT method. J Cereb Blood Flow Metab 17:1020–1032
Takeuchi R, Yonekura Y, Matsuda H et al (2002) Usefulness of a three-dimensional stereotaxic ROI template on anatomically standardised 99mTc-ECD SPET. Eur J Nucl Med Mol Imaging 29:331–341
Tamamoto F, Sumi Y, Nakanishi A et al (2000) Usefulness of cerebral blood flow (CBF) measurements to predict the functional outcome for rehabilitation in patients with cerebrovascular disease (CVD). Ann Nucl Med 14:47–52
Tateno M, Kobayashi S, Shirasaka T et al (2008) Comparison of the usefulness of brain perfusion SPECT and MIBG myocardial scintigraphy for the diagnosis of dementia with Lewy bodies. Dement Geriatr Cogn Disord 26:453–457
Tatsukawa H, Ishii K, Haranaka M et al (2005) Evaluation of average amount of cerebral blood flow measured by brain perfusion index in patients with neuropsychiatric systemic lupus erythematosus. Lupus 14:445–449
Torigai T, Mase M, Ohno T et al (2013) Usefulness of dual and fully automated measurements of cerebral blood flow during balloon occlusion test of the internal carotid artery. J Stroke Cerebrovasc Dis 22:197–204
Uezato A, Yamamoto N, Kurumaji A et al (2012) Improvement of asymmetrical temporal blood flow in refractory oral somatic delusion after successful electroconvulsive therapy. J ECT 28:50–51
Umemura A, Suzuka T, Yamada K (2000) Quantitative measurement of cerebral blood flow by 99mTc-HMPAO SPECT in acute ischaemic stroke: usefulness in determining therapeutic options. J Neurol Neurosurg Psychiatry 69:472–478
Umezaki Y, Katagiri A, Watanabe M et al (2013) Brain perfusion asymmetry in patients with oral somatic delusions. Eur Arch Psychiatry Clin Neurosci 263:315–323
Van Laere K, Van de Wiele C, Van Belle Y, et al (1999) Variability study of a non-invasive approach to the absolute quantification of cerebral blood flow with 99mTc-ECD using aortic activity as the arterial input estimate. Nucl Med Commun 20:33–40
Van Laere K, Dumont F, Koole M et al (2001) Non-invasive methods for absolute cerebral blood flow measurement using 99mTc-ECD: a study in healthy volunteers. Eur J Nucl Med 28:862–872
Walters MR, Bolster A, Dyker AG et al (2001) Effect of perindopril on cerebral and renal perfusion in stroke patients with carotid disease. Stroke 32:473–478
Zaknun JJ, Leblhuber F, Schktanz H (2008) Value of cerebral blood flow quantification in the diagnosis of dementia. Nucl Med Commun 29:260–269
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2021 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Matsuda, H. (2021). Quantification in Brain SPECT: Noninvasive Cerebral Blood Flow Measurements Using 99mTc-Labeled Tracers. In: Dierckx, R.A.J.O., Otte, A., de Vries, E.F.J., van Waarde, A., Leenders, K.L. (eds) PET and SPECT in Neurology. Springer, Cham. https://doi.org/10.1007/978-3-030-53168-3_3
Download citation
DOI: https://doi.org/10.1007/978-3-030-53168-3_3
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-53167-6
Online ISBN: 978-3-030-53168-3
eBook Packages: MedicineMedicine (R0)